GT Biopharma (GTBP) Stock Chart & Stock Price History → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free GTBP Stock Alerts $3.26 +0.03 (+0.93%) (As of 10:22 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media GT Biopharma Stock Price Performance5 Day Performance-1.21%1 Month Performance-20.87%3 Month Performance-32.37%6 Month Performance-57.88%Year-To-Date Performance-57.39%1 Year Performance-63.78% Receive GTBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> GTBP Stock Chart for Wednesday, May, 8, 2024 GTBP Chart by TradingView GT Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$3.15$3.23+2.54%$3.29$3.1713,471 shs$4.46 million05/06/2024$3.30$3.15-4.55%$3.48$3.159,715 shs$4.35 million05/03/2024$3.20$3.30+3.29%$3.50$3.302,858 shs$4.55 million05/02/2024$3.17$3.20+0.79%$3.48$3.057,792 shs$4.41 million05/01/2024$3.00$3.17+5.67%$3.38$3.044,335 shs$4.38 million04/30/2024$3.17$3.00-5.36%$3.06$2.959,467 shs$4.14 million Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$3.35$3.17-5.23%$3.33$3.029,204 shs$4.38 million04/26/2024$3.75$3.25-13.37%$3.71$3.2110,336 shs$4.49 million04/25/2024$3.58$3.75+4.79%$3.88$3.553,434 shs$5.18 million04/24/2024$3.54$3.58+1.13%$3.62$3.58372 shs$4.94 million04/23/2024$3.78$3.54-6.35%$3.83$3.5310,589 shs$4.89 million04/22/2024$3.69$3.78+2.44%$3.78$3.653,469 shs$5.22 million04/19/2024$3.87$3.65-5.68%$3.80$3.655,890 shs$5.04 million04/18/2024$3.97$3.87-2.52%$4.07$3.801,025 shs$5.34 million04/17/2024$3.70$3.97+7.30%$4.18$3.805,810 shs$5.48 million04/16/2024$3.76$3.70-1.60%$3.85$3.619,955 shs$5.11 million04/15/2024$3.90$3.76-3.59%$3.96$3.768,000 shs$5.19 million04/12/2024$4.01$3.90-2.74%$4.22$3.904,870 shs$5.38 million04/11/2024$4.00$4.01+0.25%$4.13$4.003,219 shs$5.54 million04/10/2024$4.17$4.00-4.08%$4.09$4.004,244 shs$5.52 million04/09/2024$4.12$4.17+1.21%$4.38$4.1022,826 shs$5.76 million04/08/2024$4.15$4.12-0.73%$4.49$4.0213,700 shs$5.69 million04/05/2024$4.36$4.25-2.58%$4.68$4.153,577 shs$5.87 million04/04/2024$4.64$4.36-5.98%$4.77$4.1211,975 shs$6.02 million04/03/2024$4.38$4.64+5.94%$4.68$4.274,849 shs$6.40 million04/02/2024$4.48$4.38-2.23%$4.58$4.203,829 shs$6.04 million04/01/2024$4.43$4.48+1.13%$4.58$4.1311,212 shs$6.19 million03/29/2024$4.45$4.43-0.45%$4.81$4.4310,831 shs$6.11 million03/28/2024$4.48$4.45-0.67%$4.75$4.3610,831 shs$6.14 million03/27/2024$4.48$4.48$4.48$4.323,878 shs$6.18 million03/26/2024$4.45$4.48+0.67%$4.57$4.257,704 shs$6.18 million03/25/2024$4.59$4.45-3.05%$4.65$4.3513,923 shs$6.14 million03/22/2024$3.81$4.59+20.47%$5.21$4.44138,768 shs$6.33 million03/21/2024$4.21$3.81-9.50%$4.44$3.8110,081 shs$5.25 million03/20/2024$4.47$4.21-5.71%$4.24$4.164,212 shs$5.81 million03/19/2024$4.41$4.47+1.25%$4.47$4.211,104 shs$6.16 million03/18/2024$4.63$4.41-4.75%$4.62$4.324,283 shs$6.09 million03/15/2024$4.60$4.63+0.65%$4.70$4.412,187 shs$6.39 million03/14/2024$4.60$4.60$4.76$4.551,925 shs$6.35 million03/13/2024$5.07$4.60-9.27%$5.10$4.4224,598 shs$6.35 millionIncredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide03/12/2024$4.85$5.07+4.57%$5.14$4.7062,380 shs$7.00 million03/11/2024$4.32$4.85+12.23%$4.88$4.4350,492 shs$6.69 million03/08/2024$4.41$4.31-2.19%$4.50$4.197,137 shs$5.95 million03/07/2024$4.33$4.41+1.73%$4.41$4.162,279 shs$6.08 million03/06/2024$4.30$4.33+0.74%$4.33$4.183,539 shs$5.98 million03/05/2024$4.46$4.30-3.59%$4.51$4.164,162 shs$5.93 million03/04/2024$4.40$4.46+1.36%$4.53$4.402,561 shs$6.16 million03/01/2024$4.26$4.40+3.29%$4.46$4.223,039 shs$6.07 million02/29/2024$4.28$4.26-0.47%$4.35$4.1513,048 shs$5.88 million02/28/2024$4.07$4.28+5.16%$4.38$4.155,642 shs$5.91 million02/27/2024$3.95$4.07+3.04%$4.25$3.9010,241 shs$5.62 million02/26/2024$3.87$3.95+2.07%$3.98$3.788,528 shs$5.45 million02/23/2024$4.20$3.87-7.79%$4.06$3.8710,287 shs$5.34 million02/22/2024$4.10$4.20+2.37%$4.20$4.011,885 shs$5.79 million02/21/2024$4.43$4.10-7.45%$4.49$4.025,104 shs$5.66 million02/20/2024$4.27$4.43+3.75%$4.50$4.266,362 shs$6.11 million02/19/2024$4.27$4.27$4.39$3.9320,500 shs$5.89 million02/16/2024$4.00$4.27+6.75%$4.39$3.9320,504 shs$5.89 million02/15/2024$3.76$4.00+6.52%$4.10$3.787,172 shs$5.52 million02/14/2024$3.82$3.76-1.70%$3.96$3.5290,212 shs$5.18 million02/13/2024$4.33$3.82-11.78%$4.38$3.7712,631 shs$5.27 million02/12/2024$4.80$4.33-9.79%$4.85$4.3341,327 shs$5.97 million02/09/2024$4.82$4.80-0.41%$4.82$4.717,401 shs$6.62 million02/08/2024$4.78$4.82+0.84%$4.98$4.774,170 shs$6.65 million02/07/2024$4.88$4.78-2.05%$5.07$4.737,758 shs$6.60 million Related Companies: Longeveron Stock Price Chart Exicure Stock Price Chart China Pharma Stock Price Chart Artelo Biosciences Stock Price Chart Genprex Stock Price Chart Ensysce Biosciences Stock Price Chart Tharimmune Stock Price Chart NexImmune Stock Price Chart Petros Pharmaceuticals Stock Price Chart Lipella Pharmaceuticals Stock Price Chart Receive GTBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GTBP) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.